PubRank

M G Parker

Author PubWeight™ 177.42‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 A signature motif in transcriptional co-activators mediates binding to nuclear receptors. Nature 1997 11.15
2 A modified oestrogen receptor ligand-binding domain as an improved switch for the regulation of heterologous proteins. Nucleic Acids Res 1995 7.95
3 Fatty acids, eicosanoids, and hypolipidemic agents identified as ligands of peroxisome proliferator-activated receptors by coactivator-dependent receptor ligand assay. Mol Endocrinol 1997 4.71
4 Identification of a conserved region required for hormone dependent transcriptional activation by steroid hormone receptors. EMBO J 1992 4.69
5 Nuclear factor RIP140 modulates transcriptional activation by the estrogen receptor. EMBO J 1995 4.23
6 Environmentally persistent alkylphenolic compounds are estrogenic. Endocrinology 1994 4.10
7 A variety of environmentally persistent chemicals, including some phthalate plasticizers, are weakly estrogenic. Environ Health Perspect 1995 3.47
8 Characterization and colocalization of steroid binding and dimerization activities in the mouse estrogen receptor. Cell 1990 3.37
9 Interaction of proteins with transcriptionally active estrogen receptors. Proc Natl Acad Sci U S A 1994 3.10
10 HER-2 tyrosine kinase pathway targets estrogen receptor and promotes hormone-independent growth in human breast cancer cells. Oncogene 1995 2.84
11 Identification of two transactivation domains in the mouse oestrogen receptor. Nucleic Acids Res 1989 2.70
12 Human estrogen receptor transactivational capacity is determined by both cellular and promoter context and mediated by two functionally distinct intramolecular regions. Mol Endocrinol 1994 2.62
13 Isoforms of steroid receptor co-activator 1 differ in their ability to potentiate transcription by the oestrogen receptor. EMBO J 1998 2.44
14 Estrogen receptors alpha and beta form heterodimers on DNA. J Biol Chem 1997 2.39
15 Identification of residues in the estrogen receptor that confer differential sensitivity to estrogen and hydroxytamoxifen. Mol Endocrinol 1993 2.37
16 The antiestrogen ICI 182780 disrupts estrogen receptor nucleocytoplasmic shuttling. J Cell Sci 1993 2.04
17 Inhibition of estrogen receptor-DNA binding by the "pure" antiestrogen ICI 164,384 appears to be mediated by impaired receptor dimerization. Proc Natl Acad Sci U S A 1990 2.03
18 17beta-Estradiol induces cyclin D1 gene transcription, p36D1-p34cdk4 complex activation and p105Rb phosphorylation during mitogenic stimulation of G(1)-arrested human breast cancer cells. Oncogene 1996 2.01
19 The AF1 and AF2 domains of the androgen receptor interact with distinct regions of SRC1. Mol Cell Biol 1999 2.00
20 Antiestrogen ICI 164,384 reduces cellular estrogen receptor content by increasing its turnover. Proc Natl Acad Sci U S A 1992 1.96
21 The estrogenic activity of phthalate esters in vitro. Environ Health Perspect 1997 1.94
22 Transcriptional activators differ in their responses to overexpression of TATA-box-binding protein. Mol Cell Biol 1995 1.77
23 Use of a purified outer membrane protein F (porin) preparation of Pseudomonas aeruginosa as a protective vaccine in mice. Infect Immun 1984 1.75
24 Peptide growth factors elicit estrogen receptor-dependent transcriptional activation of an estrogen-responsive element. Mol Endocrinol 1993 1.72
25 Reduction mammaplasty: an outcome analysis. Ann Plast Surg 1995 1.62
26 Identification of novel oestrogen receptor target genes in human ZR75-1 breast cancer cells by expression profiling. J Mol Endocrinol 2001 1.59
27 Functional interaction between the p160 coactivator proteins and the transcriptional enhancer factor family of transcription factors. J Biol Chem 2000 1.59
28 A consensus DNA-binding site for the androgen receptor. Mol Endocrinol 1992 1.59
29 AF-2 activity and recruitment of steroid receptor coactivator 1 to the estrogen receptor depend on a lysine residue conserved in nuclear receptors. Mol Cell Biol 1997 1.58
30 Differential effects of xenoestrogens on coactivator recruitment by estrogen receptor (ER) alpha and ERbeta. J Biol Chem 2000 1.54
31 Molecular determinants of the estrogen receptor-coactivator interface. Mol Cell Biol 1999 1.46
32 RIP-140 interacts with multiple nuclear receptors by means of two distinct sites. Mol Cell Biol 1996 1.39
33 Regulation of gene expression by nuclear hormone receptors. Curr Opin Cell Biol 1989 1.37
34 Rat prostatic steroid binding protein: DNA sequence and transcript maps of the two C3 genes. EMBO J 1983 1.35
35 An outcomes analysis and satisfaction survey of 199 consecutive abdominoplasties. Ann Plast Surg 2001 1.33
36 A comparison of transcriptional activation by ER alpha and ER beta. J Steroid Biochem Mol Biol 1999 1.31
37 Core LXXLL motif sequences in CREB-binding protein, SRC1, and RIP140 define affinity and selectivity for steroid and retinoid receptors. J Biol Chem 2000 1.29
38 Crouzon syndrome: mutations in two spliceoforms of FGFR2 and a common point mutation shared with Jackson-Weiss syndrome. Hum Mol Genet 1995 1.25
39 Mutations in the estrogen receptor ligand binding domain discriminate between hormone-dependent transactivation and transrepression. J Biol Chem 2000 1.22
40 Specific mutations in the estrogen receptor change the properties of antiestrogens to full agonists. Proc Natl Acad Sci U S A 1995 1.19
41 Cofactor competition between the ligand-bound oestrogen receptor and an intron 1 enhancer leads to oestrogen repression of ERBB2 expression in breast cancer. Oncogene 2000 1.18
42 A secretory protease inhibitor requires androgens for its expression in male sex accessory tissues but is expressed constitutively in pancreas. EMBO J 1987 1.18
43 Effects of androgens on the complexity of poly(A) RNA from rat prostate. Cell 1977 1.17
44 Hormonal regulation of protein synthesis in the rat epididymis. Characterization of androgen-dependent and testicular fluid-dependent proteins. Biochem J 1980 1.16
45 Testosterone regulates the synthesis of major proteins in rat ventral prostate. Biochem J 1978 1.14
46 Ligand-independent activation of the oestrogen receptor by mutation of a conserved tyrosine. EMBO J 1997 1.13
47 Prostatic steroid-binding protein. Isolation and characterization of C3 genes. J Biol Chem 1983 1.12
48 Androgen-regulated expression of a cloned rat prostatic c3 gene transfected into mouse mammary tumor cells. Cell 1983 1.12
49 A 22-amino-acid peptide restores DNA-binding activity to dimerization-defective mutants of the estrogen receptor. Mol Cell Biol 1990 1.11
50 A natural transactivation mutation in the thyroid hormone beta receptor: impaired interaction with putative transcriptional mediators. Proc Natl Acad Sci U S A 1997 1.10
51 Cloning and characterization of androgen-dependent mRNA from rat ventral prostate. J Biol Chem 1980 1.09
52 Nuclear receptors spring into action. Nat Struct Biol 1996 1.08
53 Mechanism of estrogen receptor-dependent transcription in a cell-free system. Mol Cell Biol 1990 1.07
54 Peptide growth factor cross-talk with the estrogen receptor requires the A/B domain and occurs independently of protein kinase C or estradiol. Endocrinology 1996 1.06
55 Socioeconomic status, marital status and hip fracture risk: a population-based case-control study. Osteoporos Int 2000 1.04
56 Mechanisms of androgen receptor activation in advanced prostate cancer: differential co-activator recruitment and gene expression. Oncogene 2007 1.04
57 Blood gases and acid-base values of unanesthetized rats exposed to hypoxia. Am J Physiol 1967 1.04
58 CAAT/enhancer binding protein is able to bind to ATF/CRE elements. Nucleic Acids Res 1991 1.02
59 Effects of testosterone on sequence complexity of polyadenylated RNA from rat seminal vesicle. Eur J Biochem 1978 1.01
60 Characterization of ligand-dependent phosphorylation of the estrogen receptor. Mol Endocrinol 1994 1.00
61 Malignancy and chronic wounds: Marjolin's ulcer. J Burn Care Rehabil 1991 1.00
62 Functional estrogen receptors in osteoblastic cells demonstrated by transfection with a reporter gene containing an estrogen response element. Mol Endocrinol 1991 0.99
63 1,4-Bis[2-(3,5-dichloropyridyloxy)]benzene, an extremely potent modulator of mouse hepatic cytochrome P-450 gene expression. Biochem J 1993 0.98
64 The prevalence of pain among the oldest old in Sweden. Pain 1996 0.97
65 COUP-TF II homodimers are formed in preference to heterodimers with RXR alpha or TR beta in intact cells. Nucleic Acids Res 1995 0.96
66 Interplay between estrogens, progestins, retinoic acid and AP-1 on a single regulatory site in the progesterone receptor gene. J Biol Chem 1994 0.96
67 Regulation of prostatic steroid binding protein mRNAs by testosterone. Mol Cell Endocrinol 1985 0.96
68 The androgenic regulation of abundant mRNA in rat ventral prostate. Eur J Biochem 1978 0.96
69 Cross-talk between Stat5b and estrogen receptor-alpha and -beta in mammary epithelial cells. J Mol Endocrinol 2001 0.94
70 Mobility limitations in the Swedish population from 1968 to 1992: age, gender and social class differences. Aging (Milano) 2000 0.94
71 Analysis of the aromatase cytochrome P450 gene in human breast cancers. J Mol Endocrinol 1994 0.93
72 Tissue-specific and hormonal regulation of the gene for rat prostatic steroid-binding protein in transgenic mice. Mol Cell Biol 1989 0.93
73 Effect of androgen on the transcription of rat prostatic binding protein genes. Mol Cell Endocrinol 1982 0.93
74 Androgen-regulated expression of secretory protein synthesis in mouse ventral prostate. Mol Cell Endocrinol 1987 0.93
75 Androgenic regulation of messenger RNA in rat epididymis. Biochem J 1980 0.92
76 Priorities in care and services for elderly people: a path without guidelines? J Med Ethics 2000 0.92
77 Identification of phosphorylation sites in the mouse oestrogen receptor. J Steroid Biochem Mol Biol 1995 0.89
78 Conditionally immortalized white preadipocytes: a novel adipocyte model. J Lipid Res 2007 0.89
79 The ultrasonic detection of soft tissue foreign bodies. Invest Radiol 1986 0.88
80 Thyroid hormone-mediated enhancement of heterodimer formation between thyroid hormone receptor beta and retinoid X receptor. J Biol Chem 1997 0.88
81 Cognitive impairments in adult mice with constitutive inactivation of RIP140 gene expression. Genes Brain Behav 2011 0.88
82 A proposed consensus steroid-binding sequence--a reply. Mol Endocrinol 1989 0.88
83 A longitudinal study of pain: reported pain from middle age to old age. Clin J Pain 1997 0.87
84 Molecular modelling of the human estrogen receptor and ligand interactions based on site-directed mutagenesis and amino acid sequence homology. J Steroid Biochem Mol Biol 1995 0.87
85 Androgen receptor-binding regions of an androgen-responsive gene. Mol Cell Endocrinol 1987 0.86
86 Cross-coupling between insulin and estrogen receptor in human neuroblastoma cells. Mol Endocrinol 1996 0.86
87 Expression of nuclear receptor interacting proteins TIF-1, SUG-1, receptor interacting protein 140, and corepressor SMRT in tamoxifen-resistant breast cancer. Clin Cancer Res 1999 0.85
88 Androgen regulated expression of a spermine binding protein gene in mouse ventral prostate. Nucleic Acids Res 1987 0.85
89 Stable transfection of the oestrogen receptor gene into a human osteosarcoma cell line. J Steroid Biochem 1989 0.84
90 Androgenic regulation of messenger RNA sequence complexity in accessory sexual tissues of the male rat studied with fractionated complementary DNA. Eur J Biochem 1979 0.84
91 Identification of constitutive and steroid-dependent transactivation domains in the mouse oestrogen receptor. J Steroid Biochem 1989 0.84
92 Influence of sociocultural and structural factors on functional ability: the case of elderly people in Bangladesh. J Aging Health 2001 0.84
93 Identification of a functional role for the 3' region of the human oestrogen receptor gene. J Mol Endocrinol 1993 0.83
94 Expression of androgen receptors and prostatic steroid-binding protein during development of the rat ventral prostate. J Endocrinol 1988 0.83
95 Effect of ligand binding and DNA binding on the structure of the mouse oestrogen receptor. J Steroid Biochem Mol Biol 1992 0.82
96 The hydrolysis of oestrone sulphate and dehydroepiandrosterone sulphate by human steroid sulphatase expressed in transfected COS-1 cells. J Steroid Biochem Mol Biol 1994 0.81
97 The progesterone receptor can regulate transcription in the absence of a functional TATA box element. J Biol Chem 1990 0.81
98 Tissue-specific differences in the binding of nuclear proteins to a CCAAT motif in the promoter of the androgen-regulated C3 gene. Mol Endocrinol 1990 0.81
99 Panniculectomy at the time of gynecologic surgery in morbidly obese patients. Am J Obstet Gynecol 2000 0.80
100 Kidney allograft biopsy: timing to complications. Clin Nephrol 2010 0.80
101 Identification of a DNA-binding site for the transcription factor GC2 in the promoter region of the p12 gene and repression of its positive activity by upstream negative regulatory elements. J Biol Chem 1990 0.80
102 Effects of antioestrogens on the DNA binding activity of oestrogen receptors in vitro. Nucleic Acids Res 1992 0.80
103 Effects of inert gases on tolerance of rats to hypoxia. J Appl Physiol 1968 0.80
104 Effects of prolactin on testosterone-induced growth and protein synthesis in rat accessory sex glands. J Endocrinol 1983 0.80
105 Use of gene transfer to study expression of steroid-responsive genes. Mol Cell Endocrinol 1984 0.80
106 Preparation of dihydrolipoamide by electrolytic reduction. FEBS Lett 1974 0.80
107 Regulation of protein synthesis in rat ventral prostate: cell-free translation of mRNA. Proc Natl Acad Sci U S A 1979 0.80
108 Use of suppressor mutants to probe the function of estrogen receptor-p160 coactivator interactions. Mol Cell Biol 2001 0.80
109 Effects of an exon 5 variant of the estrogen receptor in MCF-7 breast cancer cells. Cancer Res 1996 0.79
110 Mechanism of steroid hormone action. Cancer Surv 1986 0.79
111 The purification and regulatory properties of alpha-oxoglutarate dehydrogenase from Acineobacter iwoffi. Biochem J 1973 0.79
112 Comparison of the 90-kilodalton heat shock protein interaction with in vitro translated glucocorticoid and estrogen receptors. Mol Endocrinol 1992 0.79
113 The isocitrate dehydrogenases of Acinetobacter lwoffi. Studies on the regulation of a nicotinamide-adenine dinucleotide phosphate-linked isoenzyme. Biochem J 1973 0.78
114 Regulation of estradiol 17 beta-hydroxysteroid dehydrogenase expression and activity by retinoic acid in T47D breast cancer cells. Endocrinology 1994 0.78
115 Educational level and use of osteoporosis drugs in elderly men and women: a Swedish nationwide register-based study. Osteoporos Int 2012 0.78
116 Regulation of transcription of the eucaryotic genome. Symp Soc Dev Biol 1976 0.78
117 Aromatase activity and CYP19 gene expression in breast cancers. J Steroid Biochem Mol Biol 1996 0.78
118 Hormonal control of mRNA synthesis studied by nucleic acid hybridization. Mol Cell Endocrinol 1978 0.78
119 Oestrogen receptor mRNA and a related RNA transcript in mouse ovaries. J Mol Endocrinol 1989 0.77
120 Profound hypophosphatemia and isolated hyperphosphaturia in two cases of multiple myeloma. Am J Kidney Dis 1997 0.77
121 Analysis of oestrogen receptor dimerisation using chimeric proteins. J Steroid Biochem Mol Biol 1991 0.77
122 Organization and upstream DNA sequence of the mouse protease inhibitor gene. Nucleic Acids Res 1988 0.76
123 Effects of graded concentrations of cigarette smoke on plasma enzyme, corticosterone, and body temperature in rats. Environ Res 1978 0.76
124 Rat prostatic steroid binding protein: characterisation of the Alu element upstream of the C3 genes. Nucleic Acids Res 1984 0.76
125 Hyperkalemia and trimethoprim-sulfamethoxazole. Ann Intern Med 1996 0.75
126 Steroid sulphatase: expression, isolation and inhibition for active-site identification studies. Chem Biol Interact 1998 0.75
127 The regulation of Acinetobacter sp. alpha-oxoglutarate dehydrogenase complex. Biochem J 1972 0.75
128 Posttraumatic spindle cell nodule of the buccal mucosa. Report of a case. Oral Surg Oral Med Oral Pathol 1992 0.75
129 Effects of estrogen on gene expression in the chick oviduct. Isolation and fractionation of chromatin non-histone proteins. Biochim Biophys Acta 1976 0.75
130 Oncogenes from hormone receptors. J Endocrinol 1987 0.75
131 Serum and tissue enzymes and adrenocortical responses in rats exercised at intervals after cold acclimation. Can J Physiol Pharmacol 1972 0.75
132 Bilirubinemia and intravascular hemolysis during acclimatization to high altitude. Int J Biometeorol 1977 0.75
133 Modification of cricothyroidostomy. Ann Emerg Med 1986 0.75
134 Mapping cis-DNA regulatory elements in seminal vesicle secretion genes, prostate C3(1) gene, and the mouse mammary tumor virus-long terminal repeat DNA. Prog Clin Biol Res 1988 0.75
135 Aerobic training and the force-velocity relationship of the human quadriceps femoris muscle. J Sports Med Phys Fitness 1983 0.75
136 Androgenic regulation of poly(A)-containing RNA sequences in rat ventral prostate. J Steroid Biochem 1978 0.75
137 Interaction of rat prostate androgen receptors with polynucleotides, RNA, DNA and cloned DNA fragments. Biochim Biophys Acta 1984 0.75
138 Elder care in the priorities discussion. Hastings Cent Rep 1995 0.75
139 Serum enzyme, corticosterone and tissue changes in rats following a single oral dose of ethanol. Q J Stud Alcohol 1970 0.75
140 The incidence of vasculature at risk during cricothyroidostomy. Ann Emerg Med 1986 0.75
141 Effects of smoke on tolerance of rats to hypoxia. J Appl Physiol 1971 0.75
142 Recurrent tarsal tunnel syndrome and the radial forearm free flap. Foot Ankle Int 1996 0.75
143 Calculation of lsokinetic Rehabilitation Velocities for the Knee Extensors. J Orthop Sports Phys Ther 1982 0.75
144 Fatigue Response in Human Quadriceps Femoris Muscle during High Frequency Electrical Stimulation*. J Orthop Sports Phys Ther 1986 0.75
145 Indirect cost rates. What they are and how they reached their current levels. Cancer Invest 1990 0.75
146 Incineration and monitoring of low-level 3H and 14C wastes at a biological research institution. Health Phys 1986 0.75
147 Descriptive analysis of quadriceps and hamstrings muscle torque in high school football players*. J Orthop Sports Phys Ther 1983 0.75